
    
      A prospective, multi-center, multi-national single arm study conducted in Austria, France,
      and Germany to evaluate the performance and safety of HEMOBLASTâ„¢ Bellows in open
      gynecological, urological, ENT, head and neck, and vascular surgery. Up to 120 subjects will
      be enrolled at up to 10 sites, with a minimum of 8 subjects enrolled in each surgical
      specialty.
    
  